Recruiting Atopic Dermatitis Studies in Woodbury
A Study Evaluating BFB759 in Moderate to Severe Atopic Dermatitis
This is a double-blind, placebo-controlled study where subjects are participating for approximately 36 to 40 weeks. The study compares how well BFB759 works and how safe it is compared with a placebo....
A Study to Evaluate the Efficacy and Safety of IMG-007 in Adult Participants With Moderate-to-Severe Atopic Dermatitis
The purpose of this study is to evaluate the efficacy and safety of different dose regimens of IMG-007, compared to placebo....
About Atopic Dermatitis Clinical Trials in Woodbury
Atopic dermatitis (eczema) is a chronic inflammatory skin condition causing itchy, red, and dry skin. It is the most common form of eczema, often beginning in childhood. Treatment includes moisturizers, topical corticosteroids, immunomodulators, and newer biologics like dupilumab.
There are currently 2 atopic dermatitis clinical trials recruiting participants in Woodbury, MN. These studies are seeking a combined 445 participants. Research is being sponsored by Bluefin Biomedicine, Inc., Inmagene LLC. Clinical trial participation is free and participants receive study-related medical care at no cost.
Atopic Dermatitis Clinical Trials in Woodbury — FAQ
Are there atopic dermatitis clinical trials in Woodbury?
Yes, there are 2 atopic dermatitis clinical trials currently recruiting in Woodbury, MN. Browse the studies on this page to find one that fits.
How do I join a clinical trial in Woodbury?
Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Woodbury research site will contact you about next steps.
Are clinical trials in Woodbury free?
Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Woodbury studies also compensate for your time and travel.
What atopic dermatitis treatments are being tested?
The 2 active trials in Woodbury are testing new therapies including novel drugs, biologics, and treatment approaches for atopic dermatitis.
Data updated March 2, 2026 from ClinicalTrials.gov